Loading…

Synthesis, structure prediction, pharmacokinetic properties, molecular docking and antitumor activities of some novel thiazinone derivativesElectronic supplementary information (ESI) available. See DOI: 10.1039/c5nj01369k

A novel series of thiazinone derivatives were obtained from unexpected cyclization of dimethyl acetylenedicarboxylate (DMAD) and diethyl acetylenedicarboxylate (DEAD) with corresponding 3-alkyl-2,6-diarylpiperidin-4-one thiosemicarbazones in dry methanol without catalyst under mild conditions. The s...

Full description

Saved in:
Bibliographic Details
Main Authors: Anand, Selvam Athavan Alias, Loganathan, Chandrasekaran, Thomas, Nisha Susan, Saravanan, Kuppusamy, Alphonsa, Antony Therasa, Kabilan, Senthamaraikannan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A novel series of thiazinone derivatives were obtained from unexpected cyclization of dimethyl acetylenedicarboxylate (DMAD) and diethyl acetylenedicarboxylate (DEAD) with corresponding 3-alkyl-2,6-diarylpiperidin-4-one thiosemicarbazones in dry methanol without catalyst under mild conditions. The structures of newly synthesized compounds were established on the basis of FT-IR, HR-Mass, 1 H-NMR, 13 C-NMR, 1 H- 1 H COSY, 1 H- 13 C COSY, DEPT-135, and HMBC spectral techniques. From 1 H NMR, all newly synthesized compounds 17-24 were found to adopt chair conformation. The theoretical studies were carried out using Schrödinger software suite for the structure prediction, biochemical properties investigation and docking studies of all novel compounds. To study the antitumor activity, all the novel compounds were screened in vitro for their cytotoxicity and apoptosis activity against Hep G2 human liver cancer cell line. The biological analysis revealed that the newly synthesized compounds have good/moderate inhibitory activity against the tested cell line. Convenient synthesis of [1,3]thiazin-4-ones by the unprecedented cyclization of acetylene diesters with 3-alkyl-2,6-diarylpiperidin-4-one thiosemicarbazone derivatives and their antitumor evaluation.
ISSN:1144-0546
1369-9261
DOI:10.1039/c5nj01369k